Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5192065
Max Phase: Preclinical
Molecular Formula: C20H21NO3
Molecular Weight: 323.39
Associated Items:
ID: ALA5192065
Max Phase: Preclinical
Molecular Formula: C20H21NO3
Molecular Weight: 323.39
Associated Items:
Canonical SMILES: Cc1ccccc1CC1OC(=O)c2cc(N3CC[C@H](O)C3)ccc21
Standard InChI: InChI=1S/C20H21NO3/c1-13-4-2-3-5-14(13)10-19-17-7-6-15(11-18(17)20(23)24-19)21-9-8-16(22)12-21/h2-7,11,16,19,22H,8-10,12H2,1H3/t16-,19?/m0/s1
Standard InChI Key: PANBMLFTKYYCTD-UCFFOFKASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 323.39 | Molecular Weight (Monoisotopic): 323.1521 | AlogP: 3.02 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.99 | CX Basic pKa: 1.12 | CX LogP: 3.48 | CX LogD: 3.48 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.88 | Np Likeness Score: -0.09 |
1. Liu K, Zhou S, Zhou J, Bo R, Wang X, Xu T, Yuan Y, Xu B.. (2022) Discovery of 3, 6-disubstituted isobenzofuran-1(3H)-ones as novel inhibitors of monoamine oxidases., 67 [PMID:35472505] [10.1016/j.bmcl.2022.128748] |
Source(1):